Amelioration of Myocardial Ischemic Reperfusion Injury with Calendula Officinalis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|11|8|849-854

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.11, Iss.8, 2010-12, pp. : 849-854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 1, 2012-01 ,pp. : 46-58

Bentham Science Publishers

Access to resources Recommend Favorite

SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits

By Brunvand H.   Liu G.   Ma X.-L.   Yue T.-L.   Ruffolo R.R.   Feuerstein G.Z.  

European Journal of Pharmacology, Vol. 356, Iss. 2, 1998-09 ,pp. : 193-198

Elsevier

Access to resources Recommend Favorite

The Protein Therapy of Kallikrein in Cerebral Ischemic Reperfusion Injury

By  

Current Medicinal Chemistry, Vol. 16, Iss. 34, 2009-12 ,pp. : 4502-4510

Bentham Science Publishers

Access to resources Recommend Favorite

Endoxin Antagonist Lessens Myocardial Ischemia Reperfusion Injury

By Ke Yong-Sheng   Wang De-Guo   Wang   He-Gui   Yang Shang-Yin  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 4, 2004-07 ,pp. : 289-293

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic Potential of Monoclonal Antibodies in Myocardial Reperfusion Injury

By Nigam A.   Kopecky S.L.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 6, 2002-01 ,pp. : 367-376

Adis International

Access to resources Recommend Favorite